跳至主要内容
临床试验/NCT02870218
NCT02870218已完成2 期

Abuse Liability of Reduced Nicotine Content Cigarettes in the Context of Concurrent E-Cigarette Use

Rose Research Center, LLC1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2019年5月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
150
试验地点
1
主要终点
Expired air CO Measurement

研究概览

简要总结

Three hundred-twenty (320) adult smokers of menthol or non-menthol combustible cigarettes will be recruited and randomly assigned to one of five groups (n=64/group), who will be asked to switch for 12 weeks to ad libitum use of combustible cigarettes (matched to subjects' menthol preference) containing either 0.4, 1.4, 2.5, 5.6 or 16.9 mg nicotine (standardized nicotine yields ranging from 0.02-0.80 mg/cigarette), respectively. Each group will include 32 heavy (≥ 20 cigarettes/day), and 32 light smokers (≤10 cigarettes/day), who are hypothesized to be more sensitive to nicotine's reinforcing effects. Participants will also have free access to nicotine-containing e-cigarettes (JUUL) throughout the 12-week period. Abuse liability of combustible cigarettes will be assessed by behavioral (cigarettes/day, time to first cigarettes), self-report (rewarding effects, withdrawal symptoms) and biochemical indices (expired air carbon monoxide, cotinine blood sampling).

In laboratory sessions, we will measure nicotine thresholds for detecting and recognizing the addictive, rewarding effects of smoking. This study is designed to help the FDA identify a target nicotine threshold that will not attract young people to smoking or induce relapse in former smokers. Additionally, we will determine the level of cigarette nicotine reduction that will be tolerated without inducing dissatisfaction in smokers, information that is relevant to the FDA for designing a stepwise nicotine reduction policy that can be implemented without widespread objections. The knowledge gained from this project will greatly increase our knowledge of nicotine addiction and will help frame an FDA policy relating to the regulation of the nicotine content of tobacco. Ultimately, a well-designed nicotine reduction policy has the potential to greatly reduce the enormous toll of death and disease caused by cigarette smoking.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Basic Science
盲法
Single (Participant)

入排标准

年龄范围
21 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Subject is healthy as judged by the Investigator based on all available assessments from the Screening Period (e.g., safety laboratory, vital signs, physical examination, ECG, concomitant medications and medical history).
  • Subject smokes on average four days a week for the last 12 months.
  • Subject has no intention of quitting smoking within the next 90 days.
  • Owns a smart phone with text message and data capabilities.
  • Willingness to use and ability to operate e-cigarettes.
  • Willingness to smoke Research Cigarettes.

排除标准

  • Any medical or psychiatric condition (or associated symptoms or medications) determined by a medical professional to be severe enough to be disruptive to the study.
  • Severe or uncontrolled psychiatric disease with the exception of anxiety disorders, obsessive-compulsive disorder (OCD) and attention deficit hyperactivity disorder (ADHD);
  • Pregnant or nursing (by self-report) or positive pregnancy test;
  • Daily use of:
  • Experimental (investigational) drugs that are unknown to subject;
  • Smokeless tobacco (chewing tobacco, snuff), cigars, pipes and hookah;
  • e-cigarettes;
  • Use in the past 30 days of nicotine replacement therapy or other smoking cessation product
  • Positive drug screen for cocaine

研究组 & 干预措施

0.40mg Nicotine Cigarette w/ e-Cigarette

Active Comparator

Participants will be assigned to smoke 0.40mg nicotine Spectrum cigarettes for 12 weeks with unlimited access to JUUL e-cigarettes.

Smoking research cigarettes with e-cigarette

干预措施: Smoking research cigarettes with e-cigarette (Drug)

1.40mg Nicotine Cigarette w/ e-Cigarette

Active Comparator

Participants will be assigned to smoke 1.40mg nicotine Spectrum cigarettes for 12 weeks with unlimited access to JUUL e-cigarettes.

Smoking research cigarettes with e-cigarette

干预措施: Smoking research cigarettes with e-cigarette (Drug)

2.50mg Nicotine Cigarette w/ e-Cigarette

Active Comparator

Participants will be assigned to smoke 2.50mg nicotine Spectrum cigarettes for 12 weeks with unlimited access to JUUL e-cigarettes.

Smoking research cigarettes with e-cigarette

干预措施: Smoking research cigarettes with e-cigarette (Drug)

5.60mg Nicotine Cigarette w/ e-Cigarette

Active Comparator

Participants will be assigned to smoke 5.60mg nicotine Spectrum cigarettes for 12 weeks with unlimited access to JUUL e-cigarettes.

Smoking research cigarettes with e-cigarette

干预措施: Smoking research cigarettes with e-cigarette (Drug)

16.9mg Nicotine Cigarette w/ e-Cigarette

Active Comparator

Participants will be assigned to smoke 16.9mg nicotine Spectrum cigarettes for 12 weeks with unlimited access to JUUL e-cigarettes.

Smoking research cigarettes with e-cigarette

干预措施: Smoking research cigarettes with e-cigarette (Drug)

Halo G6 & Tribeca e-liquid

Experimental

Difference detection assessments.

Nicotine discrimination thresholds

干预措施: Nicotine discrimination thresholds (Drug)

Spectrum Research Cigarette

Experimental

Difference detection assessments.

Nicotine discrimination thresholds

干预措施: Nicotine discrimination thresholds (Drug)

结局指标

主要结局

Expired air CO Measurement

时间窗: 12 Weeks

To determine the effects of cigarette nicotine content manipulations on abuse liability as measured by exhaled breath CO.

次要结局

  • Nicotine discrimination tests to determine nicotine detection thresholds(Weeks 1, 2,8,10,12 and 14)
  • Extent of e-cigarette use based on self-report(12 Weeks)
  • Extent of e-cigarette use based on self-report cotinine levels(12 Weeks)
  • Mean number of research cigarettes smoked per day as primary index of abuse liability(12 Weeks)
  • Nicotine discrimination tests to determine nicotine recognition thresholds(Weeks 1, 2,8,10,12 and 14)

研究者

申办方类型
Industry
责任方
Principal Investigator
主要研究者

Jed Rose

President and CEO

Rose Research Center, LLC

研究点 (1)

Loading locations...

相似试验